About Fulgent Pharma
Fulgent Pharma is a company based in Temple City (United States) founded in 2011 was acquired by Fulgent Genetics in November 2022. The company has 3 employees as of December 31, 2022. Fulgent Pharma has completed 1 acquisition, including Fulgent Genetics. Fulgent Pharma offers products and services including FID-007 and Nanoencapsulation Technology. Fulgent Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Temple City, United States
- Employees 3 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Fulgent Pharma Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
3
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Fulgent Genetics
(Nov 07, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fulgent Pharma
Fulgent Pharma offers a comprehensive portfolio of products and services, including FID-007 and Nanoencapsulation Technology.
Nanoencapsulated paclitaxel for enhanced cancer treatment efficacy.
Platform to improve safety and effectiveness of anti-cancer drugs.
Funding Insights of Fulgent Pharma
Detailed funding history for Fulgent Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Fulgent Pharma
Fulgent Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fulgent Genetics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
Locked | Locked | Locked |
Investor details for Fulgent Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fulgent Pharma
Fulgent Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fulgent Genetics.
Investment portfolio details for Fulgent Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Fulgent Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Fulgent Pharma
Detailed financials for Fulgent Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fulgent Pharma Comparisons
Peer comparison for Fulgent Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fulgent Pharma
Fulgent Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
|
| Locked | Locked | Locked |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
Detailed competitors of Fulgent Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fulgent Pharma
Complete news archive for Fulgent Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fulgent Pharma
Fulgent Pharma was founded in 2011.
Fulgent Pharma is headquartered in Temple City, United States. It is registered at Temple City, California, United States.
As of Dec 31, 2022, the latest employee count at Fulgent Pharma is 3.
Fulgent Pharma was founded in 2011 and is based in Temple City, United States. Operations focus on the pharmaceutical sector, where anti-cancer drugs are enhanced through patented nanoencapsulation methods. The lead product, FID-007, involves nano-encapsulated paclitaxel and is undergoing clinical trials to improve efficacy while reducing toxicity. Established and novel anti-cancer agents are combined for targeted delivery and lower side effects.
Fulgent Pharma's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Fulgent Pharma offers FID-007 and Nanoencapsulation Technology.
Fulgent Pharma has made 1 acquisition, including Fulgent Genetics.
Fulgent Pharma has 1 investor. Key investors include Fulgent Genetics.